Jennison Associates
ALDR

Jennison Associates’s Alder Biopharmaceuticals ALDR Stock Holding History

Jennison Associates’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,183,908
Closed -$34.4M – 774
2014
Q4 		$34.4M Sell
1,183,908
-78,179
-6% -$1.4M 0.03% 381
2014
Q3 		$16M Buy
1,262,087
+1,137,087
+910% +$17.2M 0.01% 453
2014
Q2 		$2.51M Buy
+125,000
New +$1.76M ﹤0.01% 554

Other funds holding ALDR

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jennison Associates's ALDR Position: Q1 2015 in Review

Jennison Associates sold out of Alder Biopharmaceuticals (ALDR) in Q1 2015, closing a stake of 1,183,908 shares — an estimated $34.4M sold.

Jennison Associates first reported a position in ALDR in Q2 2014 and held it in 3 quarters. The position peaked at $34.4M in Q4 2014. 89 funds tracked by Wall St. Rank hold ALDR as of Q1 2015.

  • Jennison Associates reported no remaining Alder Biopharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Jennison Associates sold 1,183,908 Alder Biopharmaceuticals shares in Q1 2015, an estimated $34.4M.
  • Jennison Associates first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Jennison Associates's Alder Biopharmaceuticals position peaked at $34.4M in Q4 2014.
  • 89 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.